Appearance of Clostridium difficile infections in health care institutions in Slovakia and in the district of martin

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control and Hosp Epidemiol 2010;31; 431–45510.1086/651706Search in Google Scholar

2. Zela O, Vítek P. Infekce Clostridium difficile–stav v roce 2012. Medicína pro praxi. 2012: 9 (10): 391-394.Search in Google Scholar

3. Davies KA, Longshaw CM, Davis GL et al. (2014) Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium Difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14:1208–1219.10.1016/S1473-3099(14)70991-0Search in Google Scholar

4. McDonald LC, Sievert DM, Gould C. Vital signs: preventing Clostridium difficile infections. Morb Mortal Wkly Rep 2012; 61:157–61.Search in Google Scholar

5. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV. Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. The Med J Aus. 2014; 200 (5): 272-276.10.5694/mja13.11153Search in Google Scholar

6. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population- based study. Am J Gastroenterol 2012; 107: 89 - 95.10.1038/ajg.2011.398Search in Google Scholar

7. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV.Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. The Med J Aus. 2014; 200 (5): 272-276.10.5694/mja13.11153Search in Google Scholar

8. Viseur N, Lambert M, Delmee M, Van Broeck J, Catry B. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 200 8 to 2010. Euro Surveill 2011; 16: 2000010.2807/ese.16.43.20000-enSearch in Google Scholar

9. Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med, 2015; 372 (9): 825–834.10.1056/NEJMoa1408913Search in Google Scholar

10. Ma GK, Brensinger CM, Wu Q, Lewis JD. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study. Ann Intern Med., 2017; 167(3): 152 - 158.10.7326/M16-2733Search in Google Scholar

11. Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010; 10: 395-404.10.1016/S1473-3099(10)70080-3Search in Google Scholar

12. Arvand M¹, Vollandt D, Bettge-Weller G, Harmanus C, Kuijper EJ; Clostridium difficile study group Hesse. Increased incidence of Clostridium difficile PCR ribotype 027 in Hesse, Germany. 2011 to 2013. Eurosurveill. 2014; 19(10): 20732.10.2807/1560-7917.ES2014.19.10.20732Search in Google Scholar

13. Novakova E, Krutova M, Nyc O, Kuijper EJ, Garabasova M, Novak M, Kotlebova N, Stefkovicova S. A high prevalence of Clostridium difficile ribotypes 001 and 176 recognized within an enhanced option of European standardized Clostridium difficile infection surveillance in Slovakia, 2016; 28th ECCMID, Madrid, 2018., Abstract no739.Available from URL: https://www.escmid.org/escmid_publications/-escmid_elibrary/material/?mid=63944 [Accessed 2018 August 9th].(not yet published data)Search in Google Scholar

14. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011;53(1):42-48.10.1093/cid/cir30121653301Search in Google Scholar

15. Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881-891.10.1093/jac/dkt47724324224Search in Google Scholar

16. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med, 2015; 175 (4): 626-633.10.1001/jamainternmed.2014.827325705994Search in Google Scholar

17. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of Community-Associated Clos - tridium difficile Infection, 2009 Through 2011. JAMA Intern Med. 2013; 173 (14):1359–1367.10.1001/jamainternmed.2013.705623780507Search in Google Scholar

18. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011 Nov 3; 365 (18): 1693-703.10.1056/NEJMoa101241322047560Search in Google Scholar